Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMD for Periodontal Regeneration Post-Wisdom Tooth Extraction
NCT07059247Phase 4Not yet recruiting
- Sponsor
- Complutense University of Madrid
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 4, randomised trial of enamel matrix derivative in periodontitis (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Clinical Attachment Level at 1 year. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
enamel matrix derivative
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07059247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07059247.